Project Grant R43AG085865

Award Date 6/15/24
Completion Date 5/31/25
Dollars Obligated $500K
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
The National Institute on Aging (NIA) awarded a $499,996 Project Grant under the Aging Research federal grant program (CFDA 93.866) to Beaver Health, Inc., a minority-owned, woman-owned small business, to develop a prototype of the COMPASS conversational AI assistant. COMPASS is designed to provide personalized, culturally responsive support and coordination for Alzheimer's disease and related dementia (ADRD) caregivers in real-time. The 12-month project aims to develop and test the initial...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $349,333.00 to Rendever, Inc. to develop and test the feasibility of a new virtual reality (VR) platform tailored to support dementia caregivers. The VR-CARES initiative aims to create an immersive VR environment that enables caregivers to connect virtually, access support groups, receive training, and engage in shared experiences to alleviate feelings of loneliness and stress, and cultivate...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) totaling $956,214 will fund Ceresti Health, Inc. to develop and validate a Spanish-language version of their Caregiver-Enabled Care Program (CECP) for Hispanic/Latino families caring for loved ones with dementia. The CECP is a digital population health intervention that provides personalized education, coaching, and remote monitoring to unpaid/informal caregivers via a dedicated tablet. This project aims...
This Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $864,674 to Lifebio Inc. to develop a prototype for the LifeBioTalk platform. LifeBioTalk is a tablet-based system designed to provide stimulating audiovisual content narrated by a human-like avatar to engage people with Alzheimer's disease and related dementias. The goal is to reduce challenging behaviors and caregiver burden by promoting mental stimulation, enjoyment, and reducing...
The National Institute on Aging awarded a $232,485 Project Grant (CFDA 93.866 - Aging Research) to the University of Alabama at Birmingham (UAB) to adapt and test the feasibility of an artificial intelligence (AI)-enabled web app based on Acceptance and Commitment Therapy (ACT) for family caregivers of people with dementia. The project aims to adapt the ACT-based web app, named WEACT, through collaboration with a community advisory board, and then evaluate the feasibility, acceptability, and...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support Dr. Otis (Shaun) Owens, an Associate Professor at the University of South Carolina, to establish an independent program of translational research for supporting aging-in-place for African-Americans living with Alzheimer's disease and related dementias (ADRD) and their care partners. The $370,056 award will enable Dr. Owens to: (1) identify barriers to aging-in-place, current technology use...
This Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $241,500 to the University of California, Davis to develop and test an online Emergency Preparedness Toolkit (EPT) for spousal caregivers of patients with dementia. The goal is to engage these caregivers in planning for their own unexpected health emergencies, which can disrupt the caregiving relationship. The project will compare the ability of caregivers to identify and engage a...
This Project Grant award for $774,997, funded by the National Institute on Aging under the Aging Research program (CFDA 93.866), will support a randomized clinical trial to assess the efficacy of the CUIDATEXT text message intervention to provide caregiver support for Latino families caring for individuals with Alzheimer's disease and related dementias. The intervention, developed using user-centered principles, delivers tailored daily text messages covering five domains: disease education,...
This $1,010,230 Project Grant award, funded by the National Institute on Aging (CFDA 93.866 Aging Research), supports research to evaluate the feasibility and effectiveness of a culturally-adapted mindfulness-based program (MBP) for Latinx older adults at risk of developing Alzheimer's disease (AD). The Washington University is leading this R61 research project, which aims to address disparities in AD burden among Latinx communities through a new MBP intervention tailored to their specific...
The National Institute on Aging (NIA) awarded a $124,166 Project Grant (CFDA 93.866 - Aging Research) to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University to develop shared medical appointments (SMAs) for informal caregivers of Alzheimer's and dementia patients. The objective is to identify the most significant end-of-life concerns to create a culturally sensitive SMA curriculum that addresses knowledge gaps, improves communication, and encourages advance care...

A PERSONALIZED AND CULTURALLY RESPONSIVE MINDFULNESS VIRTUAL COACH TO SUPPORT DEMENTIA CAREGIVERS - PROJECT SUMMARY IN 2022, AN ESTIMATED 11 MILLION AMERICAN FAMILY CAREGIVERS PROVIDED 18 BILLION HOURS OF UNPAID CARE FOR INDIVIDUALS LIVING WITH ALZHEIMER'S DISEASE AND RELATED DEMENTIAS (AD/ADRD). THESE CAREGIVERS EXPERIENCE TWICE THE EMOTIONAL, PHYSICAL, AND FINANCIAL PROBLEMS AND INCREASED RISK OF DEPRESSION AND ANXIETY COMPARED TO NON-AD/ADRD CAREGIVERS. AS THE NUMBER OF PEOPLE LIVING WITH DEMENTIA IS EXPECTED TO DOUBLE TO 13.8 MILLION BY 2060, THE STRAIN ON AD/ADRD FAMILY CAREGIVERS WILL BE FURTHER INTENSIFIED, ESPECIALLY FOR MINORITIZED CAREGIVERS WHO ARE AFFECTED DISPROPORTIONATELY AND FACE CULTURAL BARRIERS IN ACCESSING SUPPORT. MINDFULNESS-BASED INTERVENTIONS HAVE BEEN SHOWN TO IMPROVE DEPRESSION, ANXIETY, AND STRESS FOR AD/ADRD FAMILY CAREGIVERS. HOWEVER, CAREGIVER ACCESS, ENGAGEMENT, AND ADHERENCE ARE CHALLENGING DUE TO BARRIERS SUCH AS TIME, COST ($50-400/SESSION), LACK OF PRIVACY IN GROUP SESSIONS, AND CULTURAL STIGMA. EXISTING CAREGIVER HEALTH AND MINDFULNESS APPS HAVE LOW ADOPTION AND POOR USABILITY, WITH PASSIVE VIDEO AND AUDIO RECORDINGS THAT ARE NOT INTERACTIVE OR PERSONALIZED TO EACH CAREGIVER'S LIFE AND CULTURAL CONTEXT. THERE IS A SIGNIFICANT UNMET NEED FOR EASILY ACCESSIBLE, PERSONALIZED, AND CULTURALLY RESPONSIVE DELIVERY OF MINDFULNESS INTERVENTIONS TO SUPPORT THE NEEDS OF DIVERSE AD/ADRD FAMILY CAREGIVERS. TO ADDRESS THIS URGENT UNMET NEED, WE ARE DEVELOPING OASIS: A PERSONALIZED AND CULTURALLY RESPONSIVE MINDFULNESS VIRTUAL COACHING PLATFORM TO REDUCE STRESS, DEPRESSION, AND ANXIETY FOR AD/ADRD CAREGIVERS. UNIQUE FROM EXISTING APPS WITH PRE-RECORDED CONTENT, OASIS LEVERAGES ADVANCES IN ARTIFICIAL INTELLIGENCE TO ADAPT ITS MINDFULNESS DELIVERY TO EACH CAREGIVER'S REAL-TIME RESPONSES, CAREGIVING AND CULTURAL CONTEXT, AND PREFERENCES. IN EACH ON-DEMAND, 1:1 SESSION, AN AVATAR, TAILORED TO THE CAREGIVER'S PREFERENCES (E.G., RACE/ETHNICITY, GENDER, ACCENT/VOICE), IS USED TO GUIDE AND SUPPORT THE CAREGIVER THROUGH PERSONALIZED MINDFULNESS COACHING. TO INCREASE ENGAGEMENT AND ADHERENCE, OASIS' NLP SYSTEM PERSONALIZES THE AVATAR'S DIALOGUE BASED ON KEY ASPECTS OF THEIR CAREGIVING EXPERIENCE AND CULTURE (E.G., CHALLENGING AD/ADRD BEHAVIORS, FAVORITE FOODS FOR MINDFUL EATING ACTIVITY, CULTURAL VALUES SUCH AS FILIAL PIETY OR FAMILISM). IN PHASE 1, OUR 12-MONTH GOALS ARE TO DEVELOP A PROTOTYPE OF OASIS AND TEST ITS INITIAL USABILITY/FEASIBILITY FOR RACIALLY AND ETHNICALLY DIVERSE AD/ADRD FAMILY CAREGIVERS. BY IMPROVING USABILITY AND PERSONALIZING INTERVENTION DELIVERY TO EACH CAREGIVER'S LIFE AND CULTURAL CONTEXT, OASIS DIRECTLY ADDRESSES BARRIERS IMPEDING MINDFULNESS AND HEALTH SUPPORT FOR AD/ADRD CAREGIVERS TO INCREASE HEALTH EQUITY BY OFFERING A PERSONALIZED, CULTURALLY RELEVANT, AND ACCESSIBLE SUPPORT SYSTEM TO THIS UNDERSERVED POPULATION.

Posted 6/14/24, 12:00 AM